Expert second opinions for tricuspid regurgitation. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Tricuspid Regurgitation (TR) is increasingly recognized as an independent predictor of poor outcomes. If you are facing a decision about tricuspid regurgitation, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Tricuspid regurgitation (TR) is increasingly recognized as an independent predictor of poor outcomes. Long considered a benign bystander, moderate-to-severe TR is associated with significantly reduced survival. The tricuspid valve has been called the "forgotten valve" because it is so frequently undertreated.
Tricuspid valve surgery is undergoing a revolution. New transcatheter devices (TriClip, EVOQUE) offer options for patients too high-risk for surgery. Concurrent tricuspid repair during left-sided valve surgery is increasingly recommended but still frequently omitted. A second opinion can identify missed opportunities for intervention.
Surgery for tricuspid regurgitation depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. Tricuspid valve surgery is undergoing a revolution. New transcatheter devices (TriClip, EVOQUE) offer options for patients too high-risk for surgery. Concurrent tricuspid repair during left-sided valve surgery is increasingly recommended but still frequently omitted. A second opinion can identify missed opportunities for intervention.
Operative mortality for tricuspid regurgitation-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for tricuspid regurgitation depends on anatomy, comorbidities, age, and personal goals. Concurrent tricuspid repair during left-sided surgery. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.